{{Drugbox
| verifiedrevid = 443584459
| IUPAC_name = (3''S'')-3-(4-chlorophenyl)-''N'',''N''-dimethyl-3-pyridin-3-ylpropan-1-amine
| image = Dexchlorpheniramine.svg
| width = 200px
| drug_name = Chlorpheniramine

<!--Clinical data-->
| tradename = Chlor-trimeton
| Drugs.com = {{drugs.com|monograph|chlorpheniramine-maleate-tannate-dexchlorpheniramine-maleate}}
| MedlinePlus = a682543
| pregnancy_category =  
| legal_AU = S3
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| IUPHAR_ligand = 1210
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 25523-97-1
| ATC_prefix = R06
| ATC_suffix = AB02
| PubChem = 33036
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01114
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 30576
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3Q9Q0B929N
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07803
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 4464
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1201353

<!--Chemical data-->
| C=16 | H=19 | Cl=1 | N=2 
| molecular_weight = 274.788 g/mol
| smiles = Clc1ccc(cc1)[C@@H](c2ncccc2)CCN(C)C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3/t15-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = SOYKEARSMXGVTM-HNNXBMFYSA-N
}}

'''Dexchlorpheniramine''' (trade name '''Polaramine''') is an [[antihistamine]] with [[anticholinergic]] properties used to treat [[allergy|allergic]] conditions such as [[hay fever]] or [[urticaria]].<ref name="pmid16390354">{{Cite journal | last1 = Theunissen | first1 = E. L. | last2 = Vermeeren | first2 = A. | last3 = Ramaekers | first3 = J. G. | doi = 10.1111/j.1365-2125.2005.02524.x | title = Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance | journal = British Journal of Clinical Pharmacology | volume = 61 | issue = 1 | pages = 79–86 | year = 2006 | pmid = 16390354 | pmc =1884990 }}</ref><ref name="pmid23680058">{{Cite journal | last1 = Ortíz San Román | first1 = L. | last2 = Sanavia Morán | first2 = E. | last3 = Campos Domínguez | first3 = M. | last4 = Peinador García | first4 = M. M. | title = Síndrome anticolinérgico por dexclorfeniramina como causa de retención urinaria | doi = 10.1016/j.anpedi.2013.02.014 | journal = Anales de Pediatría | year = 2013 | pmid = 23680058 | pmc = | volume=79 | issue=6 | pages=400–1}}</ref> It is the pharmacologically active [[dextrorotatory]] isomer of [[chlorpheniramine]].

==Pharmacology==

===Pharmacodynamics===
Dexchlorpheniramine is an [[antihistamine]], or an [[receptor antagonist|antagonist]] of the [[histamine]] [[H1 receptor|H<sub>1</sub> receptor]]. A study found that dexchlorpheniramine had a K<sub>i</sub> value of 20 to 30&nbsp;µM for the [[muscarinic acetylcholine receptor]]s using rat brain tissue.<ref name="pmid4151898">{{cite journal | vauthors = Yamamura HI, Snyder SH | title = Muscarinic cholinergic binding in rat brain | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 71 | issue = 5 | pages = 1725–9 | year = 1974 | pmid = 4151898 | pmc = 388311 | doi = | url = }}</ref>

==References==
{{Reflist|2}}

==External links==
* [http://www.drugs.com/cons/polaramine.html Polaramine consumer information]
* [http://www.drugs.com/mtm/polaramine.html Polaramine (dexchlorpheniramine) medical facts]

{{Antihistamines}}
{{Histamine receptor modulators}}
{{Muscarinic acetylcholine receptor modulators}}

[[Category:Amines]]
[[Category:Chloroarenes]]
[[Category:Enantiopure drugs]]
[[Category:H1 receptor antagonists]]
[[Category:Muscarinic antagonists]]
[[Category:Pyridines]]

{{respiratory-system-drug-stub}}